Cargando…
CDX-301 prevents radiation-induced dysregulation of miRNA expression and biogenesis
Risks of radiation exposure necessitate the development of radioprophylactic drugs. We have reported the efficacy of CDX-301, a recombinantly developed human protein form of Fms-related tyrosine kinase 3 ligand (Flt3L), as a radioprophylactic and radiomitigatory agent. Here, we performed global micr...
Autores principales: | Soni, Dharmendra Kumar, Kumar, Vidya P., Biswas, Shukla, Holmes-Hampton, Gregory P., Bhattacharyya, Sharmistha, Thomas, Lawrence J., Biswas, Roopa, Ghosh, Sanchita P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703457/ https://www.ncbi.nlm.nih.gov/pubmed/36457703 http://dx.doi.org/10.1016/j.omtn.2022.11.010 |
Ejemplares similares
-
CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice
por: Satyamitra, Merriline, et al.
Publicado: (2020) -
PrC-210 Protects against Radiation-Induced Hematopoietic and Intestinal Injury in Mice and Reduces Oxidative Stress
por: Kumar, Vidya P., et al.
Publicado: (2023) -
Pre-Administration of PLX-R18 Cells Protects Mice from Radiation-Induced Hematopoietic Failure and Lethality
por: Kumar, Vidya P., et al.
Publicado: (2022) -
Role of Non-Coding RNAs in Post-Transcriptional Regulation of Lung Diseases
por: Soni, Dharmendra Kumar, et al.
Publicado: (2021) -
Gamma Tocotrienol Protects Mice From Targeted Thoracic Radiation Injury
por: Kumar, Vidya P., et al.
Publicado: (2020)